2026 Summer JRM Quiz: #5302
The quiz is derived from the Summer 2026 JRM article, Pancreatic Neuroendocrine and Exocrine Cancer Incidence, and Stage at Diagnosis Before, During, and After the COVID-19 Pandemic, US, 2019-2022 by Suzanne Bock, MPH, S. Jane Henley, MSPH, Mary Elizabeth O’Neil, MPH, Simple D. Singh, MD, MPHm, and Manxia Wu, MD, MPH.
After reading the featured posters and completing the quiz, participants will be able to:
- Describe how pancreatic cancer incidence changed before, during, and after the COVID-19 pandemic.
- Identify patterns in stage at diagnosis for pancreatic neuroendocrine and exocrine cancers during the COVID-19 period.
- Understand how disruptions in healthcare access during COVID-19 affected cancer diagnosis trends.
Credit Information
| Activity Number | Credit Amount | Accreditation Period |
|---|---|---|
| 2026-197 | 1 CE | July 15, 2026 - July 15, 2028 |
